Combined action of EGFR tyrosine kinase inhibitors and whole-brain radiotherapy on EGFR-mutated non-small-cell lung cancer patients with brain metastasis

BACKGROUND: Lung cancer is the most common type of cancer to spread to the brain (brain metastasis [BM]). This study assessed the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in combination with whole-brain radiotherapy (WBRT) on EGFR-mutant non-small-cell lung...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yunyun, Fan, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790505/
https://www.ncbi.nlm.nih.gov/pubmed/27022274
http://dx.doi.org/10.2147/OTT.S95871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790505/
https://www.ncbi.nlm.nih.gov/pubmed/27022274
http://dx.doi.org/10.2147/OTT.S95871

Ejemplares similares